Shanghai Pharmaceuticals Holding Co., Ltd
601607
株式のランク
#2387
Shanghai Pharmaceuticals Holding Co., Ltd., a diversified investment holding... Shanghai Pharmaceuticals Holding Co., Ltd., a diversified investment holding entity established in 1994 and headquartered in Shanghai, China, plays a crucial role in the People's Republic of China's pharmaceutical and healthcare sectors. As a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd., its extensive operations encompass research, development, manufacturing, distribution, and retail of a wide array of products. The company's business model is structured around four principal segments: Production, Distribution, Retail, and an 'Others' category. Within its Production segment, it develops and manufactures a broad portfolio of pharmaceuticals, including chemical and biochemical drugs, traditional Chinese medicines, healthcare solutions, and medical devices. These offerings target diverse therapeutic fields such as oncology, cardiovascular and cerebrovascular conditions, central nervous system disorders, general infections, immunological diseases, digestive and metabolic ailments, and respiratory issues. The company's product range comprises approximately 700 distinct drug varieties. Beyond manufacturing, its Distribution arm is instrumental in providing comprehensive pharmaceutical supply chain solutions. This includes warehousing, logistics, and value-added services for various industry players, from pharmaceutical manufacturers to dispensers like hospitals, other distributors, and retail pharmacies. Furthermore, the company manages an extensive network of retail pharmacies, alongside a burgeoning online drug sales platform. This retail footprint spans approximately 2,000 chain pharmacies across 24 provinces. Its 'Others' segment encompasses a variety of support and innovative services, such as consulting, asset management, clinical trial coordination, medical assistance programs, educational initiatives for healthcare professionals and patients, e-prescription management systems, and the development of remote and cloud hospital technologies.
株価
$2.43
時価総額
$8.09B
変化（1日）
-1.16%
変化（1年）
-5.94%
国
CN
取引 Shanghai Pharmaceuticals Holding Co., Ltd (601607)
カテゴリー
Healthcare
Shanghai Pharmaceuticals Holding Co., Ltd（601607）の収益
Oct 2026 時点の収益 TTM: 0
Shanghai Pharmaceuticals Holding Co., Ltd の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Shanghai Pharmaceuticals Holding Co., Ltd の収益履歴（2001 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2025 | $40.53B | 7.48% |
| 2024 | $37.71B | 2.55% |
| 2023 | $36.77B | 9.34% |
| 2022 | $33.63B | -0.96% |
| 2021 | $33.96B | 15.59% |
| 2020 | $29.38B | 9.64% |
| 2019 | $26.79B | 15.85% |
| 2018 | $23.13B | 15.00% |
| 2017 | $20.11B | 15.62% |
| 2016 | $17.39B | 7.05% |
| 2015 | $16.25B | 8.92% |
| 2014 | $14.92B | 15.68% |
| 2013 | $12.90B | 18.12% |
| 2012 | $10.92B | 25.36% |
| 2011 | $8.71B | 53.65% |
| 2010 | $5.67B | 97.75% |
| 2009 | $2.87B | 18.19% |
| 2008 | $2.43B | 27.21% |
| 2007 | $1.91B | 30.42% |
| 2006 | $1.46B | 10.27% |
| 2005 | $1.33B | 1.43% |
| 2004 | $1.31B | 10.52% |
| 2003 | $1.18B | 35.26% |
| 2002 | $874.21M | 39.06% |
| 2001 | $628.65M | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| $410.98B | - |
US
|
|
| - | - |
US
|
|
| $254.25B | - |
US
|
|
| - | - |
US
|
|
| $7.64B | - |
AU
|
